ATE543910T1 - Verfahren und materialien zur herstellung von simvastatin und verwandten verbindungen - Google Patents

Verfahren und materialien zur herstellung von simvastatin und verwandten verbindungen

Info

Publication number
ATE543910T1
ATE543910T1 AT07777257T AT07777257T ATE543910T1 AT E543910 T1 ATE543910 T1 AT E543910T1 AT 07777257 T AT07777257 T AT 07777257T AT 07777257 T AT07777257 T AT 07777257T AT E543910 T1 ATE543910 T1 AT E543910T1
Authority
AT
Austria
Prior art keywords
materials
methods
related compounds
producing simvastatin
simvastatin
Prior art date
Application number
AT07777257T
Other languages
English (en)
Inventor
Yi Tang
Xinkai Xie
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Application granted granted Critical
Publication of ATE543910T1 publication Critical patent/ATE543910T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/30Oxygen atoms, e.g. delta-lactones
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02Oxygen as only ring hetero atoms
    • C12P17/06Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • A61K31/366Lactones having six-membered rings, e.g. delta-lactones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/1025Acyltransferases (2.3)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/1025Acyltransferases (2.3)
    • C12N9/1029Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/40Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
    • C12P7/42Hydroxy-carboxylic acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/62Carboxylic acid esters

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Pyrane Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT07777257T 2006-05-24 2007-05-24 Verfahren und materialien zur herstellung von simvastatin und verwandten verbindungen ATE543910T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US80808806P 2006-05-24 2006-05-24
PCT/US2007/012362 WO2007139871A2 (en) 2006-05-24 2007-05-24 Methods and materials for making simvastatin and related compounds

Publications (1)

Publication Number Publication Date
ATE543910T1 true ATE543910T1 (de) 2012-02-15

Family

ID=38779209

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07777257T ATE543910T1 (de) 2006-05-24 2007-05-24 Verfahren und materialien zur herstellung von simvastatin und verwandten verbindungen

Country Status (11)

Country Link
US (4) US8211664B2 (de)
EP (1) EP2032715B1 (de)
KR (1) KR101455794B1 (de)
CN (1) CN101490271B (de)
AT (1) ATE543910T1 (de)
BR (1) BRPI0711889B8 (de)
CA (1) CA2652883C (de)
IL (1) IL195341A (de)
MX (1) MX2008014778A (de)
RU (1) RU2447152C2 (de)
WO (1) WO2007139871A2 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0711889B8 (pt) 2006-05-24 2021-05-25 Univ California método para produção de sinvastatina, composição de matéria, método para fabricação de huvastatina, método para fabricação de sinvastatina, e método para fabricação de uma composição de matéria de sinvastatina ou huvastatina
WO2009056539A1 (en) * 2007-10-30 2009-05-07 Dsm Ip Assets B.V. Fermentative production of simvastatin
KR100959001B1 (ko) 2007-12-27 2010-05-20 선웨이 바이오테크 코., 엘티디. 알츠하이머병을 예방 및 치료하기 위한 조성물 및 그제조방법
ES2343049B1 (es) * 2008-10-15 2011-06-10 Neuron Biopharma, S.A. Biosintesis de derivados de monacolina j.
CN102574896B (zh) 2009-09-30 2015-04-08 科德克希思公司 变异LovD多肽及其用途
US9499803B2 (en) * 2009-10-08 2016-11-22 The Regents Of The University Of California Variant LovD polypeptide
CN102695792B (zh) * 2009-10-08 2015-02-18 加利福尼亚大学董事会 对辛伐他汀合成表现出改善性质的LovD突变体
CN102043030A (zh) * 2009-10-22 2011-05-04 北京万全阳光医学技术有限公司 一种用高效液相色谱法测定烟酸辛伐他汀缓释片有关物质的方法
CN102010831B (zh) * 2010-05-26 2012-04-18 云南农业大学 一种产洛伐他汀紫色红曲菌霉mpt13
PL222067B1 (pl) * 2011-08-11 2016-06-30 Inst Biotechnologii I Antybiotyków Kaseta ekspresyjna, zastosowanie kasety ekspresyjnej, wektor ekspresyjny, komórka prokariotycznego gospodarza zawierająca wektor ekspresyjny, szczep bakteryjny oraz sposób wytwarzania polipeptydu
EP2730655A1 (de) * 2012-11-12 2014-05-14 Evonik Industries AG Verfahren zur Umsetzung eines Carbonsäureesters unter Verwendung BioH-defizienter Zellen
CN104342417A (zh) * 2013-08-09 2015-02-11 南京朗恩生物科技有限公司 源于土曲霉的活性增强的酰基转移酶突变体
CN103772248B (zh) * 2014-01-06 2016-06-08 苏州汉酶生物技术有限公司 一种辛伐他汀侧链的酰基供体制备方法
CN103725727B (zh) * 2014-01-06 2016-06-08 苏州汉酶生物技术有限公司 一种辛伐他汀铵盐的制备方法
CN103772247B (zh) * 2014-01-06 2016-06-08 苏州汉酶生物技术有限公司 一种可用于合成辛伐他汀铵盐的酰基供体的制备方法
US20150315621A1 (en) * 2014-04-30 2015-11-05 The Regents Of The University Of California One-pot fermentation process for simvastatin production
KR101656235B1 (ko) * 2014-10-07 2016-09-12 대한민국 신규 스코풀라리옵시스 브레비카울리스 m2479 균주 및 이의 용도
CN105586325A (zh) * 2016-01-29 2016-05-18 重庆西南合成制药有限公司 一种洛伐他汀酰基转移酶突变体
CN108118042B (zh) * 2016-11-30 2021-01-15 中国科学院青岛生物能源与过程研究所 2-甲基丁酸侧链水解酶和产莫纳可林j的曲霉菌株及其构建方法与应用
CN111655855B (zh) 2017-09-14 2025-09-09 生命明疗法股份有限公司 人治疗靶标及其调节剂
CN109402086B (zh) * 2018-02-05 2020-08-11 中国科学院青岛生物能源与过程研究所 一种2-甲基丁酸侧链水解酶及其表达菌株和应用
EP3824071A4 (de) 2018-07-17 2022-04-20 Conagen Inc. Biosynthetische herstellung von gamma-lactonen
CN110857441B (zh) * 2018-08-24 2022-07-29 中国科学院青岛生物能源与过程研究所 一种产莫纳可林j的曲霉菌及其构建方法与应用
CN113557259B (zh) 2019-03-21 2024-03-08 科纳根公司 使用具有亚末端羟化酶活性的细胞色素P450酶生物合成生产γ-内酯和δ-内酯

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6391583B1 (en) 1998-12-18 2002-05-21 Wisconsin Alumni Research Foundation Method of producing antihypercholesterolemic agents
CZ2003554A3 (cs) * 2000-07-27 2003-08-13 Plus Chemicals, B. V. Vysoce přečištěný simvastatin
AU2002337601A1 (en) * 2001-07-25 2003-02-17 International Centre For Genetic Engineering And Biotechnology Process for the preparation of simvastatin
BRPI0711889B8 (pt) * 2006-05-24 2021-05-25 Univ California método para produção de sinvastatina, composição de matéria, método para fabricação de huvastatina, método para fabricação de sinvastatina, e método para fabricação de uma composição de matéria de sinvastatina ou huvastatina
CN101473040A (zh) * 2006-06-20 2009-07-01 帝斯曼知识产权资产管理有限公司 生产辛伐他汀的方法
WO2009077523A2 (en) 2007-12-18 2009-06-25 Dsm Ip Assets B.V. Improved statin production
CN102574896B (zh) 2009-09-30 2015-04-08 科德克希思公司 变异LovD多肽及其用途

Also Published As

Publication number Publication date
US20180355391A1 (en) 2018-12-13
US9970037B2 (en) 2018-05-15
US20120315680A1 (en) 2012-12-13
EP2032715A4 (de) 2010-12-15
KR20090016488A (ko) 2009-02-13
US10793884B2 (en) 2020-10-06
US20090191602A1 (en) 2009-07-30
BRPI0711889B1 (pt) 2019-12-24
WO2007139871A3 (en) 2008-12-24
CA2652883C (en) 2016-01-05
BRPI0711889B8 (pt) 2021-05-25
EP2032715A2 (de) 2009-03-11
US8951754B2 (en) 2015-02-10
KR101455794B1 (ko) 2014-11-03
WO2007139871A2 (en) 2007-12-06
MX2008014778A (es) 2009-01-28
US20150203884A1 (en) 2015-07-23
CA2652883A1 (en) 2007-12-06
IL195341A0 (en) 2011-08-01
IL195341A (en) 2017-01-31
EP2032715B1 (de) 2012-02-01
RU2447152C2 (ru) 2012-04-10
US8211664B2 (en) 2012-07-03
CN101490271B (zh) 2014-03-12
RU2008151159A (ru) 2010-06-27
CN101490271A (zh) 2009-07-22
BRPI0711889A2 (pt) 2012-01-10

Similar Documents

Publication Publication Date Title
ATE543910T1 (de) Verfahren und materialien zur herstellung von simvastatin und verwandten verbindungen
ATE531827T1 (de) Verfahren zur herstellung des titanpulvers
EP1934354A4 (de) Verfahren zur herstellung von hybridsaat
DE602007012559D1 (de) H die schleimhaut
ATE430480T1 (de) Verfahren zur herstellung von nährmittelzusammensetzungen
DE502007002159D1 (de) Verfahren zur Herstellung von Diarylcarbonat
DE502006000218D1 (de) Verfahren zur Herstellung von SiOC-verknüpften, linearen Polydialkylsiloxan-Polyoxyalkylen-Blockcopolymeren
EP2014783A4 (de) Verfahren zur herstellung von feuerverzinktem stahlblech und feuerverzinktes stahlblech
DE502006000138D1 (de) Verfahren zur Herstellung von Triorganosiloxygruppen aufweisenden Organopolysiloxanen
ATE447593T1 (de) Niedrigviskose uretdiongruppenhaltige polyadditionsverbindungen, verfahren zur herstellung und verwendung
DE502006000036D1 (de) Kontinuierliches Verfahren zur Herstellung SiOC-enthaltender Verbindungen
DE502006006498D1 (de) Verfahren zur Herstellung von Organopolysiloxanen
ATE552250T1 (de) Verfahren zur herstellung von duloxetin und verwandten verbindungen
DE602004021435D1 (de) Injizierbare zusammensetzung zur behandlung von krebs
ATE516290T1 (de) Verfahren zur herstellung von buprenorphin und derivaten von buprenorphin
DE502007000875D1 (de) Verfahren zur Herstellung von ß-Ketocarbonyl-funktionellen Organosiliciumverbindungen
DE602006010302D1 (de) Verfahren zur Herstellung von 5-methyl-2-furfural
DE502007000339D1 (de) Verfahren zur Herstellung von Urethangruppen aufweisenden Organosiliciumverbindungen
DE602006018699D1 (de) Verfahren zur Herstellung von Fluorhalogenethern
EP1914220A4 (de) Verfahren zur herstellung von 2-hydroxyestern
DE602006009562D1 (de) Verfahren zur herstellung von ferrisuccinylcasein
ATE496914T1 (de) Verfahren zur synthese von triazolen
EP2274293A4 (de) Verfahren zur synthese von kotalanol und stereoisomeren und analogen davon, und durch das verfahren hergestellte neue verbindungen
DE112006000985A5 (de) Verfahren zur Herstellung von Tetrahydropyranen aus Tetrahydropyran-3-onen
DE502007003652D1 (de) Verwendung von nitratsalzen zur unterdrückung störender gerüche